- Thailand is considering switching from Chinese vaccines to Western vaccines to protect medical staff.
- The country is considering providing AstraZeneca vaccine to those who have already been vaccinated.
- This happened after 600 vaccinated workers were infected with Covid-19, which added to the problem of vaccination in China.
- For more stories, please visit Business Insider.
Thai officials seemed to have lost confidence in the Chinese-made vaccines they provided to medical staff and advised them to receive a booster shot of AstraZeneca.
This On Monday, the National Committee on Infectious Diseases made recommendationsIt was made after more than 600 medical staff were still infected with Covid-19 after being injected with two doses of Sinovac vaccine.
This decision is one of several decisions made recently to leave Konosing and comes from As the effectiveness of the vaccine is more widely questioned.
Indonesia Friday It is announced that health workers who have received the Xenoxin vaccine will be vaccinated with Moderna vaccine.
It followed Bahrain and UAE It also provided a third opportunity for those who initially chose Kexing.
According to the data from The Ministry of Health of Thailand issued on Saturday, 677,348 Thai medical staff received two doses of Koxing vaccine Between April and July 10.
Of these, 618 were infected with the coronavirus, although they were fully vaccinated.
Most people-597 out of 618-either have no symptoms or have only mild Covid-19. The data showed that 19 people were infected with a moderate disease.
One nurse died and another health worker was described as critical.
Last month, Indonesia reported that more than 350 health workers have been fully vaccinated Sinovac vaccine received Covid-19, Of which about two dozen have been hospitalized.
The 10 Indonesian doctors who died of Covid-19 in June have been fully vaccinated. The Guardian reports.
When the news broke, Thailand was implementing similar lockdown measures to curb its deadliest Covid-19 outbreak to date, which was triggered by the Delta variant. Al Jazeera reported on Monday.
There are still questions about the efficacy of the vaccine, especially for the Delta variant
Many news media questioned whether the Chinese vaccine can prevent Delta variants, Including insider, After a surge in cases in highly vaccinated countries that rely on these vaccines.
The efficacy of the vaccine is unclear, because different trials have produced different results.
Data from Turkish trials Published on Thursday in the peer-reviewed journal The Lancet, The vaccine was found to be 83.5% effective against symptomatic infections.
This trial was conducted when the Alpha variant first appeared in the UK Dominate in Turkey.
Real-world data in Indonesia monitored approximately 128,000 vaccinated medical staff between January and March and found that the vaccine is more protective: 94% prevent infection 96% effectively prevent hospitalization.
This was before the more vaccine-resistant Delta variant appeared in the country.
This time a less active trial in Brazil showed that Sinovac’s efficacy is about 50%, while at this time another variant, Zeta, Dominate in the country.
China is investigating the effects of its injections against the more contagious delta variant, The Wall Street Journal reported on July 9.
